Table 3.
Correlation of AKIP1 expression with clinical characteristics
| Items | AKIP1 expression | P value | |
|---|---|---|---|
| High (n = 201) | Low (n = 118) | ||
| Age (n/%) | |||
| ≤60 y | 93 (64.1) | 52 (35.9) | .703 |
| >60 y | 108 (62.1) | 66 (37.9) | |
| Gender (n/%) | |||
| Male | 162 (62.5) | 97 (37.5) | .723 |
| Female | 39 (65.0) | 21 (35.0) | |
| Tumor size (n/%) | |||
| ≤5 cm | 105 (57.7) | 77 (42.3) | .023 |
| >5 cm | 96 (70.1) | 41 (29.9) | |
| Lymph node metastasis (n/%) | |||
| No | 115 (58.4) | 82 (41.6) | .029 |
| Yes | 86 (70.5) | 36 (29.5) | |
| TNM stage (n/%) | |||
| I | 54 (50.5) | 53 (49.5) | .001 |
| II | 65 (65.0) | 35 (35.0) | |
| III | 82 (73.2) | 30 (26.8) | |
| Pathological differentiation (n/%) | |||
| Well | 26 (53.1) | 23 (46.9) | .074 |
| Moderate | 127 (63.2) | 74 (36.8) | |
| Poor | 48 (69.6) | 21 (30.4) | |
Data were presented as count (percentage). Comparison was determined by chi‐square test or Wilcoxon rank‐sum test. P value < .05 was considered significant.
Abbreviations: AKIP1, A‐kinase‐interacting protein 1; TNM, tumor node metastasis.